Clinical Trial Update: Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELO

View source ↗

Summary

TerSera Therapeutics completed a real-world evidence study evaluating patient-reported outcomes for XERMELO (telotristat ethyl) in carcinoid syndrome, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Syndrome

Drugs mentioned

• XERMELO (telotristat ethyl)

Snippet

Sponsor: TerSera Therapeutics LLC | Conditions: Carcinoid Syndrome | Status: COMPLETED | Results posted: 2024-07-15